U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. AUDENZ
  1. Vaccines, Blood & Biologics

STN: 125692
Proper Name: Influenza A (H5N1) Monovalent Vaccine, Adjuvanted
Tradename: AUDENZ
Manufacturer: Seqirus, Inc.
Indication:

  • AUDENZ is an inactivated vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine.
  • AUDENZ is approved for use in persons 6 months of age and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.

Product Information

Supporting Documents

Back to Top